1-((tert-Butoxycarbonyl)amino)azetidine-3-carboxylic acid, 97%, 100mg

2-Ethoxyethyl Methacrylate (stabilized with MEHQ)>98.0%(GC)500mL

(R)-7-(But-2-ynyl)-8-(3-(1,3-dioxoisoindolin-2-yl)piperidin-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione, 98%, 10g

3-Chloro-2-(3-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine, 95%, 500mg

Methyl 3-oxo-5-phenylpentanoate, 95%, 500mg

2-[3-(4-nitrophenyl)-1-phenyl-1h-pyrazol-4-yl]acetic acid, 97%, 100mg

1-(3,3,3-Trifluoropropyl)piperidin-4-one, 95%, 100mg

3,5-Dibromo-4-iodo-tert-butylbenzene, 90.0%, 5g

N~1~,N~1~-dimethyl-1-(1-methyl-1H-pyrrol-2-yl)ethane-1,2-diamine, 95.0%, 500mg

Manganese AAS standard solution, ROTI®Star, 500 ml, HDPE

4-Bromophenylglyoxal hydrate, 95+%, 5g

1-(2-(Trifluoromethyl)pyridin-4-yl)ethan-1-ol, 500mg

1-tert-Butyl 3-methyl 3-methylpiperidine-1,3-dicarboxylate, 95.0%, 100g